1 poster presented in 2022
2 posters presented in 2018
2 posters presented in 2017
2022
Narayanan S. Commercial Payer and Rare Disease Patient Stakeholder Perspectives on Incorporation of Direct Patient Input on Value of Medicines in Payer Formulary Decision-Making Process in the U.S. Poster Presentation at AMCP 2022, March 29-April 1, 2022, Chicago, USA.
2018
Narayanan S, Olesen D. Management of Duchenne Muscular Dystrophy (DMD): Results From a Survey of US Healthcare Providers. Poster Presentation at AMCP Annual Meeting, April 23-26, 2018, Boston, USA.
Carlton R, Regan T, Narayanan S. The Budget Impact Of Deflazacort For The Treatment Of Duchenne Muscular Dystrophy (DMD). Poster Presentation at AMCP Annual Meeting, April 23-26, 2018, Boston, USA.
2017
Narayanan S, Souza M. Dosing Patterns Associated With Deflazacort Observed In The Early Access Program For Patients With Duchenne Muscular Dystrophy In The U.S. Poster Presentation at the AMCP Nexus 2017 Conference, Oct 16-19, 2017, Dallas, USA.
Narayanan S, Jin F, Souza M, Shao D, Gala S, Elfring G, Trifillis P, Ong T, Peltz SW, Darras BT, Shieh PB. Comparison Of Deflazacort And Prednisone/Prednisolone In Duchenne Muscular Dystrophy: Results From The Post-Hoc Analysis Of Placebo Arm Of Phase-3 ACT DMD. Poster Presentation at the AMCP Nexus 2017 Conference, Oct 16-19, 2017, Dallas, USA
To request more information, send us an email at info@avant-health.com